group 1 pah: current therapies
Post on 31-Dec-2015
31 Views
Preview:
DESCRIPTION
Group 1 PAH: Current Therapies. Group 4 CTEPH. Prostacyclin Pathway: Modulation by Available Agents. SERAPHIN: Primary End Point*. Prostacyclin Pathway: Modulation by Investigational Agents. CTEPH: Lung Tissue Samples Show Distal Arteriopathy. - PowerPoint PPT Presentation
TRANSCRIPT
Group 1 PAH: Current Therapies
Group 4 CTEPH
Prostacyclin Pathway: Modulation by Available Agents
SERAPHIN: Primary End Point*
Prostacyclin Pathway: Modulation by Investigational Agents
CTEPH: Lung Tissue Samples Show Distal Arteriopathy
Recent/Ongoing Trials: Address Previously Unmet Needs
Use of Other PAH Therapies
PATENT-1: Hypotension
Angiogenesis and PDGF: Modulation by Tyrosine Kinase
Inhibitors
PATENT-1 and SERAPHIN at ESC
References
References (cont)
References (cont)
Abbreviations
Abbreviations (cont)
top related